Sponsor pipeline

RenovoRx clinical trial pipeline

Get alerts when RenovoRx's trials change

2 active trials 2 recruiting 1 Phase 3 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-25
Primary completion pushed: 2026-06 → 2027-06
Completion pushed: 2026-09 → 2027-09
NCT03257033 Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy… · Phase 3

Active trials by phase

Phase 3
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT03257033 Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy… Locally Advanced Pancreatic Cancer Recruiting 2026-08-24
Not specified
NCT06805461 PumaRx Registry Trial Solid Tumors Recruiting 2026-03-30

Disease areas by active trials

Pancreatic Cancer (1)

Get alerts when RenovoRx's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free